FR2303533A1 - Dehydro-13,14 desoxy-11 prostaglandines et procede de leur preparation - Google Patents

Dehydro-13,14 desoxy-11 prostaglandines et procede de leur preparation

Info

Publication number
FR2303533A1
FR2303533A1 FR7607349A FR7607349A FR2303533A1 FR 2303533 A1 FR2303533 A1 FR 2303533A1 FR 7607349 A FR7607349 A FR 7607349A FR 7607349 A FR7607349 A FR 7607349A FR 2303533 A1 FR2303533 A1 FR 2303533A1
Authority
FR
France
Prior art keywords
desoxy
dehydro
prostaglandins
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7607349A
Other languages
English (en)
French (fr)
Other versions
FR2303533B1 (en, 2012
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Carlo Erba SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carlo Erba SpA filed Critical Carlo Erba SpA
Publication of FR2303533A1 publication Critical patent/FR2303533A1/fr
Application granted granted Critical
Publication of FR2303533B1 publication Critical patent/FR2303533B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/12—1,4-Dioxanes; Hydrogenated 1,4-dioxanes not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C07F9/5407—Acyclic saturated phosphonium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR7607349A 1975-03-14 1976-03-15 Dehydro-13,14 desoxy-11 prostaglandines et procede de leur preparation Granted FR2303533A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT21264/75A IT1037126B (it) 1975-03-14 1975-03-14 13.4 deidro ii desossi prosta glandine

Publications (2)

Publication Number Publication Date
FR2303533A1 true FR2303533A1 (fr) 1976-10-08
FR2303533B1 FR2303533B1 (en, 2012) 1979-09-28

Family

ID=11179220

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7607349A Granted FR2303533A1 (fr) 1975-03-14 1976-03-15 Dehydro-13,14 desoxy-11 prostaglandines et procede de leur preparation

Country Status (20)

Country Link
US (1) US4198430A (en, 2012)
JP (1) JPS5846510B2 (en, 2012)
AT (1) AT357699B (en, 2012)
BE (1) BE839533A (en, 2012)
CA (1) CA1103242A (en, 2012)
CH (1) CH618680A5 (en, 2012)
CS (1) CS189001B2 (en, 2012)
CY (1) CY1113A (en, 2012)
DE (1) DE2610503C2 (en, 2012)
DK (1) DK147070C (en, 2012)
FR (1) FR2303533A1 (en, 2012)
GB (2) GB1531567A (en, 2012)
HK (1) HK24881A (en, 2012)
HU (1) HU175728B (en, 2012)
IL (1) IL49189A (en, 2012)
IT (1) IT1037126B (en, 2012)
MY (1) MY8200137A (en, 2012)
NL (1) NL7602646A (en, 2012)
SE (1) SE428922B (en, 2012)
ZA (1) ZA761538B (en, 2012)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2408589A1 (fr) * 1977-11-15 1979-06-08 Erba Carlo Spa Nouvelles 13,14-bisdeshydroprostaglandines, leur procede de preparation et leurs applications therapeutiques

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU501803B2 (en) * 1975-03-21 1979-06-28 Farmitalia Carlo Erba S.P.A. Fluoro-prostaglandins
ZA77160B (en) * 1976-02-13 1977-11-30 Upjohn Co Prostaglandin analogs
US4328355A (en) * 1976-12-27 1982-05-04 G. D. Searle & Co. Prostaglandin derivatives having aryl, hydroxyl, and alkynyl functions in one side chain
US4149006A (en) * 1977-01-24 1979-04-10 G. D. Searle & Co. Prostaglandin derivatives having alkynyl, hydroxy and aryloxy junctions in the 2β side chain
US4576962A (en) * 1983-10-19 1986-03-18 The Procter & Gamble Company Prostaglandin analogues
EP2875022B1 (en) 2012-07-19 2016-10-12 Cayman Chemical Company, Incorporated Difluorolactam compounds as ep4 receptor-selective agonists for use in the treatment of ep4-mediated disease and conditions

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2187335A1 (en, 2012) * 1972-04-14 1974-01-18 Searle & Co

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3935234A (en) * 1971-08-17 1976-01-27 Universal Oil Products Company Chemical condensation improvement

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2187335A1 (en, 2012) * 1972-04-14 1974-01-18 Searle & Co

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2408589A1 (fr) * 1977-11-15 1979-06-08 Erba Carlo Spa Nouvelles 13,14-bisdeshydroprostaglandines, leur procede de preparation et leurs applications therapeutiques

Also Published As

Publication number Publication date
IT1037126B (it) 1979-11-10
DE2610503A1 (de) 1976-09-30
ATA184076A (de) 1979-12-15
MY8200137A (en) 1982-12-31
ZA761538B (en) 1977-03-30
HK24881A (en) 1981-06-12
CH618680A5 (en, 2012) 1980-08-15
US4198430A (en) 1980-04-15
IL49189A (en) 1980-03-31
JPS51115448A (en) 1976-10-12
JPS5846510B2 (ja) 1983-10-17
BE839533A (fr) 1976-07-01
CS189001B2 (en) 1979-03-30
NL7602646A (nl) 1976-09-16
DK147070C (da) 1984-09-10
CY1113A (en) 1981-12-04
CA1103242A (en) 1981-06-16
AU1191376A (en) 1977-09-15
FR2303533B1 (en, 2012) 1979-09-28
GB1531568A (en) 1978-11-08
AT357699B (de) 1980-07-25
IL49189A0 (en) 1976-05-31
DK147070B (da) 1984-04-02
DK110476A (da) 1976-09-15
DE2610503C2 (de) 1986-09-18
SE428922B (sv) 1983-08-01
SE7603223L (sv) 1976-09-15
HU175728B (hu) 1980-10-28
GB1531567A (en) 1978-11-08

Similar Documents

Publication Publication Date Title
BE862514A (fr) Prostaglandines bicycliques et leur procede de preparation
FR2307833A1 (fr) Procede de preparation de polyphenylene-ethers
BE843241A (fr) Procede de preparation de nouveaux 2-piperinoalcoyl-1,4-benzodioxannes
BE847090A (fr) 15-steroides, et leur procede de preparation
FR2307530A1 (fr) Triaryl-1,1,1 alkylamines et leur procede de preparation
FR2313357A1 (fr) Procede de preparation du 1,4-diaminoanthraquinone-2,3-dinitrile
FR2303533A1 (fr) Dehydro-13,14 desoxy-11 prostaglandines et procede de leur preparation
FR2285866A1 (fr) N or-o-cycloalkyl dehydro-13,14 prostaglandines et procede de leur preparation
BE847331A (fr) Procede de preparation de 4-alkyl-thiosemi-carbazides,
BE845327A (fr) Procede de preparation de 4,4'-dihydroxy-3-3'-5-5'-tretralcoyldiphenylalcanes
BE832364A (fr) 17 alpha-hydroxy-1,3,5(10), 15-oestratetraenes et leur procede de preparation
FR2299865A1 (fr) Arylmethyl-1 imidazolidones-2 et leur procede de preparation
FR2299300A1 (fr) Trihalogeno-1,1,1-methyl-4-pentene-3-ols-2 et leur procede de preparation
BE844739A (fr) Procede de preparation de cyclohexane-diones-1,3
FR2347370A1 (fr) 7-amino-3-tetrazolyl substitue-thiomethyl-cephalosporines et leur procede de preparation
FR2318166A1 (fr) Procede de preparation continue de 2,5-dioxo-1-oxa-2-phospholanes
FR2333792A1 (fr) 4-hydroxymethyl-2-pyrrolidinones et leur procede de preparation
BE839291A (fr) Procede de preparation de 4-acylaminocanthrones
BE846563A (fr) Procede de preparation de 2-oxo-oxazolidines
BE845980A (fr) Procede de preparation de polypropylene-polyamines
FR2313359A1 (fr) Prostaglandines pgfb et leur procede de preparation
BE844257A (fr) Procede de preparation de 7,8-epoxy-2-methyloctadecane
FR2329267A2 (fr) Styrylamidines et leur procede de preparation
BE831305A (fr) Hydroxyphenyl-piperidones substituees, leur procede de preparation et leur application
FR2313036A1 (fr) Nouvelles thienyl-prostaglandines, leur procede de preparation et leur application

Legal Events

Date Code Title Description
CD Change of name or company name
TP Transmission of property
ST Notification of lapse